CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on genomics, today announced that Chairman and CEO Thomas R. Mika is scheduled to present at the 6
Annual OneMedForum conference on Wednesday, January 9, 2013, at 10:20 a.m. Pacific Standard Time. The January 7-9 conference is to be held at the Sir Francis Drake Hotel in San Francisco.
Annual OneMedForum will feature over 100 emerging growth companies showcasing the most innovative technology in life sciences. Conference attendees include institutional investors, high net worth individual investors, family offices and business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.
The conference features companies from all sectors of life sciences and various levels of clinical development, seeking the establishment of a global presence. This year, special attention is paid to promising technologies in health technology, medical devices and diagnostics, complementing a strong presence of traditional biotech innovation.
CollabRx uses cloud-based expert systems to inform healthcare decision-making by aggregating and contextualizing the world’s knowledge on molecular medicine with specific insights from the nation’s top clinical experts. The company combines proprietary content and technology to provide clinically relevant and dynamically updated knowledge on clinical trials, drugs, biologics and other information relevant for cancer treatment planning. This knowledge is supported by CollabRx’s large and growing network of over 50 leading clinical practitioners in the United States. While CollabRx and its advisors do not provide specific treatment recommendations, this clinically relevant knowledge is a key part of the “context engine” for informing healthcare decision-making.
Established in 2008, OneMedForum is the conference component of OneMedPlace, which provides an integrated media platform to showcase the best ideas and innovations in health and medicine globally. The media platform also includes: OneMedRadio, OneMedTV, OneMedSentinel, a global database of companies, and OneMedResearch, which tracks promising lesser-known microcap public companies. More information may be obtained at
CollabRx, Inc. (NASDAQ: CLRX) is a data analytics company and a leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at